Cited 0 time in
Effect of Canagliflozin (CANA) in Patients With Type 2 Diabetes Mellitus (T2DM) Who Were, or Were Not, on Antihyperglycemic Agents (AHAs) at Screening
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김경아 | - |
| dc.date.accessioned | 2024-10-30T15:43:54Z | - |
| dc.date.available | 2024-10-30T15:43:54Z | - |
| dc.date.issued | 2014-06-13 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/50635 | - |
| dc.title | Effect of Canagliflozin (CANA) in Patients With Type 2 Diabetes Mellitus (T2DM) Who Were, or Were Not, on Antihyperglycemic Agents (AHAs) at Screening | - |
| dc.type | Conference | - |
| dc.citation.startPage | 280 | - |
| dc.citation.endPage | 280 | - |
| dc.citation.conferenceName | American Diabetes Association Meeing | - |
| dc.citation.conferencePlace | 미국 | - |
| dc.citation.conferencePlace | 모스코네센터 | - |
| dc.citation.conferenceDate | 2014-06-13 ~ 2014-06-17 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
